<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00822146</url>
  </required_header>
  <id_info>
    <org_study_id>CEN_G_CA_11</org_study_id>
    <nct_id>NCT00822146</nct_id>
  </id_info>
  <brief_title>Cardiac Resynchronization Therapy (CRT) Efficacy Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Bakken Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this research study is the invasive evaluation of CR therapy efficacy in patients&#xD;
      treated with an InSync Sentry device using an external monitoring device to obtain important&#xD;
      cardiac parameters.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>classified</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRT</intervention_name>
    <description>classified</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient indicated for InSync Sentry CRT device implant&#xD;
&#xD;
          -  The patient must be willing and capable of following the study protocol&#xD;
&#xD;
          -  EF â‰¤ 40%&#xD;
&#xD;
          -  Systolic pulmonary artery pressure derived by echocardiography &gt; 40&#xD;
&#xD;
          -  Patients with their device functioning in a bi-ventricular mode, with defibrillation&#xD;
             detection and therapy enabled&#xD;
&#xD;
          -  Marked released transvenous RVCoil lead&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic AF&#xD;
&#xD;
          -  Patients with unipolar atrial or unipolar right ventricular leads&#xD;
&#xD;
          -  Patients needing a Lower Rate faster than 110 beats per minute&#xD;
&#xD;
          -  Patients with an implanted Medtronic Sentry in whom missing one day's&#xD;
             fluid-measurement value is undesirable&#xD;
&#xD;
          -  Patients who cannot tolerate turning off Rate Response during the study&#xD;
&#xD;
          -  Patients with acute ischemia&#xD;
&#xD;
          -  Patients whose InSync Sentry battery is at ERI or EOL status&#xD;
&#xD;
          -  Patients with &quot;RAMware&quot; downloaded from other studies&#xD;
&#xD;
          -  Patients with medical conditions that would limit study participation&#xD;
&#xD;
          -  Patients who are pregnant&#xD;
&#xD;
          -  Patients enrolled in another study, which could influence the result of this study&#xD;
&#xD;
          -  Patients on the heart transplantation list or patients with transplanted hearts&#xD;
&#xD;
          -  Patients is not available for follow-up care&#xD;
&#xD;
          -  Patients has not signed a consent form&#xD;
&#xD;
          -  Patients with renal failure needing dialysis&#xD;
&#xD;
          -  Patients whose compliance can expected to be poor&#xD;
&#xD;
          -  Patients with a mechanical tricuspid valve&#xD;
&#xD;
          -  Life expectation &lt; 12 months&#xD;
&#xD;
          -  Severe PAOD (peripheral arterial occlusive disease)&#xD;
&#xD;
          -  Underage patients, pregnant or breast feeding women and female patients not using&#xD;
             adequate contraception are excluded from participating in the study&#xD;
&#xD;
        Since right after implantation study procedure will follow, patient has to sign the&#xD;
        informed consent before the implantation. However the following criteria are device based&#xD;
        and can therefore not checked at time of sign off.&#xD;
&#xD;
        Therefore lead performance will be checked right after the implant and before the study&#xD;
        specific procedure. If exclusion criteria are fulfilled patient exit the study and no study&#xD;
        specific procedure will be done.&#xD;
&#xD;
          -  Patients with non-intact or unstable leads, as indicated on the &quot;Quick Look&quot; screen of&#xD;
             the Medtronic Model 2090 programmer by the presence of lead warnings such as the&#xD;
             following:&#xD;
&#xD;
               -  LV pacing lead impedance is &gt; 2500 ohms&#xD;
&#xD;
               -  LV pacing lead impedance is &lt; 200 ohms&#xD;
&#xD;
               -  A. pacing lead impedance is &gt; 2500 ohms&#xD;
&#xD;
               -  A. pacing lead impedance is &lt; 200 ohms&#xD;
&#xD;
               -  SVC defib lead impedance is &gt; 200 ohms&#xD;
&#xD;
               -  SVC defib lead impedance is &lt; 20 ohms&#xD;
&#xD;
               -  RV pacing lead impedance is &gt; 2500 ohms&#xD;
&#xD;
               -  RV pacing lead impedance is &lt; 200 ohms&#xD;
&#xD;
          -  Patients with atrial pacing thresholds lower than 1.0 volts at .03 ms&#xD;
&#xD;
          -  Patients with right ventricular pacing thresholds lower than 1.0 volts at .03 ms&#xD;
&#xD;
          -  Patients with left ventricular pacing thresholds lower than 1.0 volts at .03 ms&#xD;
&#xD;
          -  Patients in whom a Lower Rate cannot be programmed to achieve consistent atrial pacing&#xD;
             for the duration of download software installed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>January 13, 2009</study_first_submitted>
  <study_first_submitted_qc>January 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2009</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CRT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

